AFP and cancer: Additionally, a decline in AFP levels serves as a prognostic indicator, with a slow rate of decline implying less effective chemotherapy against malignancies.[6] Therefore, non‐invasive and ultrasensitive biomarker detection devices are required to facilitate early diagnosis, which could improve cancer therapeutic interventions and patient outcomes.